Zobrazeno 1 - 10
of 157
pro vyhledávání: '"V Brossa"'
Autor:
Nuria Mesado, Alessandro Sionis, Jesús Álvarez-García, Mercedes Rivas-Lasarte, Alba Maestro, V. Brossa, Eduard Solé-González, Paula Fluvià, Laura López-López, Juan Fernández-Martínez, Maria Jose Pirla, Sonia Mirabet, Juan Cinca, Eulalia Roig
Publikováno v:
European Journal of Heart Failure. 21:1605-1613
Aims Lung ultrasound (LUS) is a useful tool with which to assess subclinical pulmonary congestion and to stratify the prognosis of patients with heart failure (HF). The aim of this study was to evaluate whether an LUS-guided follow-up protocol improv
Autor:
N Mas Malagarriga, M Gomis Pastor, A De Dios López, V. Brossa Loidi, D Medina Catalan, L. López López, S. Ros Abarca, E Roig Mingell, N Jorba Bertran, MA Mangues Bafalluy, S. Mirabet Pérez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Multimorbidity and therapeutic complexity are undermining health outcomes in chronic populations. Medication non-adherence may be a consequence of this complexity and is a direct cause of graft loss and death after a heart t
Autor:
Mercedes Rivas-Lasarte, Nuria Mesado, Jesús Álvarez-García, Isabel Zegrí-Reiriz, Carles Moliner-Abós, Diana Mojón Álvarez, V. Brossa, L. Lopez, Sonia Mirabet, Eduard Solé-González, Eulalia Roig, Paula Fluvià-Brugues, Julia Pamies Besora, Maria Jose Pirla, Laia Carla Belarte
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Frontiers in Physiology
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
IntroductionSacubitril/valsartan (SV) promotes cardiac remodeling and improves prognosis in patients with heart failure (HF). However, the response to the drug may vary between patients and its implementation in daily clinical practice has been slowe
Autor:
Eulalia Roig, Francesc Garcia-Cuyàs, V. Brossa, Mar Gomis-Pastor, Esther Rodriguez-Murphy, Albert Salazar, Anna Feliu, Elisabeth Galvez-Tugas, M Antonia Mangues, Laura Mora López, Gerardo Ontiveros, Sonia Mirabet
Publikováno v:
JMIR Cardio, Vol 4, Iss 1, p e19065 (2020)
JMIR Cardio
JMIR Cardio
Background Solid organ transplantation could be the only life-saving treatment for end-stage heart failure. Nevertheless, multimorbidity and polypharmacy remain major problems after heart transplant. A technology-based behavioral intervention model w
Autor:
Eulalia Roig, L. Lopez, V. Brossa, D Garcia-Coscuella, F Aran, R Ortega, M. Campreciós, N. Mesado, T Moreno, A Ruiz, S. Mirabet, I. Zegri Reiriz
Publikováno v:
European Heart Journal. 41
Background Natriuresis is gaining growing interest in identifying diuretic resistance (DR) patients. However, it has not been proved useful beyond the first day with intravenous (iv) furosemide. Moreover, data regarding urinary chlorine (uCl) or urin
Autor:
V Brossa, Enrique Rodríguez-Font, Z L Moreno Weidmann, X Vinolas-Prat, Concepción Alonso-Martín, J Guerra-Ramos, B Campos-Garcia, F Mendez-Zurita
Publikováno v:
EP Europace. 22
Introduction Women are frequently underrepresented in clinical trials for heart failure. Differences on cardiovascular background may imply differences on indications, device election and outcomes in patients receiving cardiac devices (CRT and ICD).
Autor:
Carles Moliner-Abós, V. Brossa, Julia Pamies Besora, Eduard Solé-González, Paula Fluvià-Brugues, L. Lopez, Eulalia Roig, Nuria Mesado, Jesús Álvarez-García, Sonia Mirabet, Maria Jose Pirla, Mercedes Rivas-Lasarte
Publikováno v:
Cardiovascular drugs and therapy. 33(3)
Sacubitril/valsartan reduced heart failure (HF) admissions and cardiovascular mortality in the PARADIGM-HF trial. However, real-life studies are scarce comparing daily practice patients with those of the trial. The aim of our study was to analyze the
Autor:
S. Mirabet Pérez, S. Ros Abarca, L. López López, A. de Dios López, E. Roig Minguell, N. Mas Malagarriga, M. Manges Bafalluy, Mar Gomis-Pastor, V. Brossa Loidi
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S282
Purpose Non-adherence is a main issue after heart transplantation. The main objective of this study is to evaluate if a mHealth-based strategy is better than the conventional approach to improve adherence in adults heart transplanted recipients and t
Autor:
Laura Mora López, Eulalia Roig, V. Brossa, Anna Barata, Mar Gomis-Pastor, Andreu Ferrero-Gregori, Anna Feliu, Sonia Mirabet, Jan Thomas De Pourcq, M Antonia Mangues, Irene Conejo
Publikováno v:
JMIR mHealth and uHealth
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
JMIR mHealth and uHealth, Vol 8, Iss 2, p e15957 (2020)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
JMIR mHealth and uHealth, Vol 8, Iss 2, p e15957 (2020)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Background Medication nonadherence in heart transplant recipients (HTxR) is related to graft loss and death. mHeart is a mobile app that uses electronic patient-reported outcome measures (ePROMs) to identify and manage medication nonadherence in the
Autor:
Eulalia Roig, Esther Rodriguez-Murphy, Andreu Ferrero, V. Brossa, Maria Antonia Mangues, J.T. De Pourcq, M. Gomis, Anna Feliu, Sonia Mirabet, A. Aretio, L. Lopez
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S273-S274
Purpose Non-adherence to immunosuppressive medications following organ transplant ranges from 20-40% and is associated with episodes of acute rejection and graft loss. This would justify implementing multidisciplinary interventions designed to improv